Scarica l'app Stockscreener
27.80
5.85%
1.4709
Precedente Chiudi:
$26.33
Aprire:
$26.26
Volume 24 ore:
96,203
Relative Volume:
0.06
Capitalizzazione di mercato:
$1.58B
Reddito:
$308.05M
Utile/perdita netta:
$-95.57M
Rapporto P/E:
-16.16
EPS:
-1.72
Flusso di cassa netto:
$-58.34M
1 W Prestazione:
-3.90%
1M Prestazione:
+13.15%
6M Prestazione:
-8.35%
1 anno Prestazione:
-51.95%
Intervallo 1D:
$26.06
$28.00
Intervallo di 1 settimana:
$25.83
$29.50
Portata 52W:
$19.35
$66.85
Procept Biorobotics Corp Stock (PRCT) Company Profile
Nome
Procept Biorobotics Corp
Settore
Industria
Telefono
(650) 232-9832
Indirizzo
150 BAYTECH DRIVE, SAN JOSE
Compare PRCT vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
27.79 | 1.50B | 308.05M | -95.57M | -58.34M | -1.72 |
ABT
Abbott Laboratories
|
86.53 | 149.10B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
303.22 | 116.96B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
74.47 | 94.76B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.27 | 71.81B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.80 | 49.79B | 6.30B | 1.07B | 1.09B | 1.8406 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-06 | Iniziato | Robert W. Baird | Neutral |
| 2026-02-26 | Downgrade | BofA Securities | Neutral → Underperform |
| 2026-02-26 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-12-12 | Iniziato | UBS | Buy |
| 2025-12-08 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-09-02 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2025-07-09 | Iniziato | Stephens | Overweight |
| 2025-07-07 | Iniziato | Oppenheimer | Perform |
| 2024-12-02 | Iniziato | Morgan Stanley | Overweight |
| 2024-11-14 | Iniziato | Jefferies | Hold |
| 2023-08-11 | Iniziato | Piper Sandler | Overweight |
| 2023-05-31 | Iniziato | William Blair | Outperform |
| 2022-10-31 | Iniziato | BTIG Research | Neutral |
| 2022-10-25 | Iniziato | Truist | Buy |
| 2022-09-02 | Iniziato | Wells Fargo | Overweight |
| 2022-07-15 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-06-23 | Iniziato | B. Riley Securities | Buy |
| 2021-10-11 | Iniziato | BofA Securities | Buy |
| 2021-10-11 | Iniziato | Cowen | Outperform |
| 2021-10-11 | Iniziato | Goldman | Neutral |
| 2021-10-11 | Iniziato | Guggenheim | Buy |
| 2021-10-11 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Procept Biorobotics Corp Borsa (PRCT) Ultime notizie
PROCEPT BioRobotics (PRCT) Is Down 9.2% After Aquablation WATER IV MilestonesWhat's Changed - Yahoo Finance
PROCEPT BioRobotics (PRCT) Is Down 6.0% After WATER IV Trial Milestones – Has The Bull Case Changed? - simplywall.st
Procept secures FDA IDE for Aquablation and completes WATER IV study enrolment - Medical Device Network
PRCT Stock Price, Quote & Chart | PROCEPT BIOROBOTICS CORP (NASDAQ:PRCT) - ChartMill
Procept Biorobotics wins expanded FDA IDE for Aquablation, completes study enrollment - MassDevice
Siemens Healthineers, AiM team up; Procept completes study enrollment - Yahoo Finance
PROCEPT Biorobotics® Advances Prostate Cancer Program With WATER IV Study Enrollment Completion And Expanded IDE Approval - marketscreener.com
PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval - markets.businessinsider.com
Procept BioRobotics completes enrollment in prostate cancer study - Investing.com
Only FDA randomized study tests robotic waterjet prostate surgery vs removal - Stock Titan
A Look At PROCEPT BioRobotics (PRCT) Valuation After Its Better Than Expected Q1 Earnings And Analyst Updates - simplywall.st
Here’s What the Street Thinks About PROCEPT BioRobotics Corporation (PRCT) - Insider Monkey
Lisanti Capital Growth LLC Buys Shares of 35,890 PROCEPT BioRobotics Corporation $PRCT - MarketBeat
DNB Asset Management AS Has $3.13 Million Stock Position in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Will Stronger AUA Aquablation Guidelines Across Prostate Sizes Change PROCEPT BioRobotics' (PRCT) Narrative? - simplywall.st
AllianceBernstein (PRCT) discloses 147,327 shares; 0.3% stake reported - Stock Titan
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
A Look At PROCEPT BioRobotics (PRCT) Valuation As AUA Guideline Update Expands Aquablation Opportunity - Sahm
Pinnacle Associates Ltd. Takes Position in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics stock (US74271T1060): Sharp decline signals market caution - AD HOC NEWS
AUA Guidelines Strengthen Recommendation for Aquablation® Therapy - GlobeNewswire
Waterjet prostate surgery gets stronger support in new urology guidelines - Stock Titan
TradingKey - TradingKey
PROCEPT BioRobotics (NASDAQ:PRCT) Trading Up 7.4%Should You Buy? - MarketBeat
Q1 Results Say a Lot About Procept Biorobotics Corp (PRCT) Stock Outlook - Insider Monkey
8 Best Small Cap Robotics Stocks to Buy According to Analysts - Insider Monkey
Should PROCEPT BioRobotics’ Reaffirmed 2026 Outlook Amid Wider Losses Require Action From PRCT Investors? - Sahm
Mitsubishi UFJ Asset Management Co. Ltd. Has $5.38 Million Position in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics Corporation $PRCT Shares Sold by Comerica Bank - MarketBeat
C WorldWide Group Holding A S Purchases 225,000 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
UBS Group AG Increases Position in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
A Look At PROCEPT BioRobotics (PRCT) Valuation After Q1 Earnings And Reaffirmed Growth Guidance - simplywall.st
Does Stronger Aquablation Tailwinds And Reaffirmed 2026 Guidance Change The Bull Case For PROCEPT (PRCT)? - Sahm
PRCT SEC FilingsProcept Biorobotics Corp 10-K, 10-Q, 8-K Forms - Stock Titan
How The PROCEPT BioRobotics (PRCT) Investment Story Is Shifting After Q4 Miss And Guidance Reset - Yahoo Finance
Latest PRCT NewsPROCEPT BioRobotics Corporation Announces C... - Stock Titan
Assessing PROCEPT BioRobotics (PRCT) Valuation After Mixed Q1 2026 Results And Share Price Weakness - Sahm
PROCEPT BioRobotics Corp Q1 2026 Financial Results and SEC 10-Q Filing Highlights - Minichart
PROCEPT BioRobotics (PRCT)’s Growth Narrative Improves Following Aquablation Upgrade and HYDROS Launch - Insider Monkey
PROCEPT BioRobotics Q1 Loss Deepens To US$0.56 EPS And Tests Bullish Revenue Narratives - simplywall.st
Procept Biorobotics Charts Growth Amid Profit Pressures - TipRanks
PRCT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
PROCEPT BioRobotics (PRCT) CTO reports share and option stakes - Stock Titan
PROCEPT BioRobotics (NASDAQ: PRCT) Q1 2026 revenue rises 20% - Stock Titan
PROCEPT BioRobotics to Attend Three Upcoming Investor Conferences in May & June - Moomoo
Procept Biorobotics Corp Azioni (PRCT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.19%
1.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):